OBJECTIVE: To compare the incidence of postoperative nausea and vomiting (PONV) and postoperative pain in thyroidectomy patients undergoing general anaesthesia, with or without bilateral superficial cervical plexus block (BSCPB). METHODS: In this prospective, randomized, doubleblind study, adult patients scheduled for thyroid surgery under general anaesthesia were randomized to receive BSCPB with 20 ml 0.5% ropivacaine (ropivacaine group) or placebo (20 ml saline; saline group) before surgery. The incidence of PONV and postoperative pain, and the need for rescue antiemetics were assessed at 0 -24 h postoperatively. RESULTS: Data from 135 patients were evaluated and the incidence of PONV, the need for rescue antiemetics and the number of patients needing additional perioperative pain relief in the postanaesthetic care unit were significantly lower in the ropivacaine group compared with the saline group. Early postoperative (0 -8 h) visual analogue scale pain scores were significantly lower in the ropivacaine group compared with the saline group. CONCLUSIONS: BSCPB with 0.5% ropivacaine administered before surgery can significantly reduce the incidence of PONV and early postoperative pain and also reduce perioperative opioid requirements in thyroidectomy patients undergoing general anaesthesia.
Introduction
Postoperative nausea and vomiting (PONV) is a common complication after thyroidectomy and the incidence has been reported to reach 63 -84% if no prophylactic antiemetic is administered. 1 -3 The volatile anaesthetics, nitrous oxide and opioids have all been demonstrated to be anaesthetic risk factors for PONV. 4 Postoperative pain is also considered to increase the incidence of PONV. 5, 6 Using different anaesthetic modalities to reduce PONV risk factors is considered to be a very important perioperative approach.
A combination of regional and general anaesthesia may be used to decrease the depth of general anaesthesia, provide prolonged postoperative analgesia and H-D Cai, C-Z Lin, C-X Yu et al. Bilateral superficial cervical plexus block and PONV reduce opioid requirements. 7 Although, cervical plexus block has been shown to be an effective technique to alleviate pain during and immediately after thyroidectomy, 7, 8 few studies have investigated the incidence of PONV in patients under general anaesthesia with cervical plexus block.
The present study aimed to test the hypothesis that adjunct bilateral superficial cervical plexus block (BSCPB) with general anaesthesia in patients undergoing thyroidectomy may reduce the incidence of PONV and the postoperative pain score. The primary endpoint was the incidence of PONV in patients under general anaesthesia who were randomized to receive BSCPB with 0.5% ropivacaine or received placebo (saline) before thyroid surgery. Secondary endpoints were postoperative pain score, perioperative analgesic requirement and adverse effects related to BSCPB.
Patients and methods

STUDY POPULATION
Consecutive euthyroid patients of American Society of Anesthesiologists physical status 1 or 2, 9 who were scheduled to undergo thyroidectomy under general anaesthesia at the First Affiliated Hospital of Fujian Medical University, Fujian, China, between March and December 2010, were randomly enrolled into the study. Patients were excluded from the study if they had coagulation disorders, history of allergy to aminoamide local anaesthetic, local sepsis, diaphragmatic motion abnormality, intrathoracic goitre, or had a difficult endotracheal intubation (> 2 tracheal intubation attempts) during induction of anaesthesia. Patients were also excluded if they had a history of PONV, motion sickness, gastrointestinal disorders, or had received antiemetics in the 24 h preceding surgery.
Study approval was obtained from the Human Investigations Ethics Committee of the First Affiliated Hospital of Fujian Medical
University and all patients provided written informed consent prior to participation.
STUDY DESIGN AND ANAESTHESIA PROTOCOL
General anaesthesia was induced with 2.0 -2.5 mg/kg propofol intravenously (i.v.) and 2.0 µg/kg fentanyl i.v. Tracheal intubation was facilitated by administration of 0.15 mg/kg vecuronium i.v. General anaesthesia was maintained with 0.5 -2.0% (inspired concentration) sevoflurane and 60% nitrous oxide in oxygen. The concentration of sevoflurane was adjusted to maintain a bispectral (BIS) index between 40 and 60. Additional doses of 50 -100 µg fentanyl were administered as bolus i.v. doses for variations in systolic blood pressure and heart rate of ≥ 20% from values measured before operation. Standard monitoring of ventilatory variables and respiratory gases was done throughout. Muscle relaxation was maintained with vecuronium i.v. as required.
Immediately after endotracheal intubation and a negative aspiration test for blood, patients were randomized, using a computer-generated sequence of random numbers and sealed envelopes, to receive either BSCPB with 10 ml of 0.5% plain ropivacaine (ropivacaine group) on each side or 10 ml isotonic sodium chloride solution (saline group) on each side. The local anaesthetic solution was prepared in unlabelled syringes by a trained nurse. An anaesthesiologist, familiar with the BSCPB technique and blinded to the treatment allocation, performed the BSCPB with a 22gauge subcutaneous short bevelled needle inserted at the midpoint of the lateral border of the sternocleidomastoid muscle while the H-D Cai, C-Z Lin, C-X Yu et al.
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patient was under general anaesthesia and before incision. A total of 6 ml of the injected solution was administered in both cranial and caudal directions along the lateral border of the muscle and 4 ml was injected horizontally above the muscle in each site at a depth of 1 -2 cm. The randomization process and the identity of the study treatment were unknown to the patient, the anaesthesiologist during surgery and the investigators (H. Thyroidectomy was performed by the same surgeon in all cases with patients in the supine position, with the neck slightly hyperextended. The concentration of volatile anaesthetic (sevoflurane) was decreased to 0.4% during skin suturing. Volatile anaesthetic and nitrous oxide were then discontinued simultaneously and the lungs were manually ventilated with 100% oxygen with a fresh gas flow of 8 l/min until spontaneous ventilation started. Patients received 0.5 mg atropine i.v. and 1.0 mg neostigmine i.v. if neuromuscular reversal of residual paralysis was required. All patients were extubated and admitted to the postanaesthesia care unit (PACU) at the First Affiliated Hospital of Fujian Medical University for 2 h following surgery.
STUDY ASSESSMENTS
Demographic data (including age, sex and weight), medication used, relevant medical history, duration of anaesthesia (from the point of induction of anaesthesia to extubation) and duration of operation (from the point of incision to the end of the procedure) were recorded for each patient. Patients were observed and data collected immediately after surgery and every 4 h during the first 24 h postsurgery by a team of trained nurses and anaesthetists who were blinded to the treatment allocation. Arterial blood pressure, heart rate and respiratory rate were also monitored. The occurrence of any adverse effects that might be related to the regional anaesthetic technique, such as cervical epidural analgesia and diaphragmatic palsy, were also monitored for and recorded every 4 h postsurgery.
Occurrences of nausea, vomiting, and total postoperative nausea and vomiting (PONV), severity of nausea (recorded on a visual analogue scale [VAS]: 0, no nausea; 10, worst imaginable nausea), and rescue antiemetic drug use were monitored every 4 h during the postoperative observation period (except when patients were asleep). A nausea score was recorded for each episode of nausea, but only the highest scores recorded in the early (0 -8 h) and late (8 -24 h) observation periods were entered into the statistical analyses. Patients who reported intolerable nausea were treated with 4 mg ondansetron i.v. as rescue antiemetic. For data collection, incidences of tolerable and intolerable nausea were combined and recorded as nausea; incidences of retching (spasmodic contractions of abdominal wall and diaphragmatic muscles without expulsion of gastric content), vomiting alone (same as retching but with forceful expulsion of gastric contents), and vomiting with nausea were all recorded as vomiting.
Postoperative pain was also assessed every 4 h during the 24 h postsurgery observation period using a 0 -10 VAS (0, no pain; 10, worst imaginable pain). The mode of perioperative pain management for all patients was 1 mg/kg flubiprofen i.v. every 12 h, with the first dose administered 40 min prior to the end of surgery. In the case of a VAS pain score > 6, or patients complaining of pain and requesting analgesia, an additional analgesia dose of 50 µg fentanyl i.v was injected. The requirement for H-D Cai, C-Z Lin, C-X Yu et al. Bilateral superficial cervical plexus block and PONV additional perioperative fentanyl was also assessed in the 2 h that the patients remained in the PACU.
STATISTICAL ANALYSES
The estimated minimum sample size of 65 patients per group was predetermined by using a power analysis based on two assumptions: (i) that the incidence of PONV without antiemetic prophylaxis would be 70% in patients undergoing thyroidectomy with inhalation anaesthesia; 1 -4,10 and (ii) that a 25% reduction in the incidence of PONV (from 70% to 45%) would be clinically relevant (α = 0.05 [two-tailed]); β = 0.1 [power = 90%]).
All statistical analyses were performed using SPSS ® statistical package version 11.5 (SPSS Inc., Chicago, IL, USA) for Windows ® . The distribution of the data was evaluated for normality with the Kolmogorov-Smirnov test. Normally distributed data were presented as mean ± SD and non-normally distributed data were presented as median with 25th and 75th percentile ranges. Nonnormally distributed data were analysed with the Wilcoxon signed-rank test. Normally distributed data comprising continuous variables were analysed using the Student's t-test or one-way analysis of variance (ANOVA), as appropriate and the χ 2 -test was used for categorical data. Repeated measures (nausea VAS scores, pain VAS scores) were analysed by the Mann-Whitney U test and repeated measures ANOVA. A P-value ≤ 0.05 was considered to be statistically significant.
Results
A total of 140 patients were enrolled in the study. Five patients were excluded: four patients (two in the saline group and two in the ropivacaine group) had difficult intubations and one patient in the ropivacaine group had postoperative bleeding. Final study numbers, therefore, were 68 in the saline group and 67 in the ropivacaine group. There were no statistically significant differences between the saline and ropivacaine groups in terms of weight, sex, age, duration of surgery and duration of anaesthesia ( Table 1 ). The groups also did not differ with respect to arterial blood pressure, heart rate and respiratory rate, which were stable for all patients during the 24-h observation period (data not shown). There was no statistically significant between-group difference (20 and 17 patients in the saline and ropivacaine groups, respectively) in the use of the Data presented as mean ± SD or n of patients.
No statistically significant between-group differences (P > 0.05); Student's t-test and Fisher's exact test. Bilateral superficial cervical plexus block and PONV neuromuscular reversal agents 0.5 mg atropine i.v. and 1.0 mg neostigmine i.v. The incidence of PONV was signficantly lower in the ropivacaine group than in the saline group in the 0 -4 h postanaesthesia time period (P = 0.001) and in the 0 -24 h postanaesthesia time period (P < 0.001, Table  2 ). Significantly fewer patients in the ropivacaine group required rescue antiemetics than in the saline group during the 0 -4 h postanaesthesia time period (P = 0.015) and in the 0 -24 h postanaesthesia time period (P = 0.010, Table 2 ). The nausea score in the ropivacaine group was significantly lower than in the saline group (mean ± SD 2.24 ± 3.10 versus 4.04 ± 3.09, respectively, P = 0.001). Perioperative analgesic requirements were significantly higher in the saline group than in the ropivacaine group: the mean ± SD additional dose of intraoperative fentanyl was 208 ± 49 µg in the saline group versus 158 ± 31 µg in the ropivacaine group (P < 0.001) and the requirement for fentanyl in the PACU (0 -2 h after surgery) was 59% (40/68 patients) in the saline group versus 19% (13/67 patients) in the ropivacaine group (P < 0.001). Postoperative VAS pain scores in the ropivacaine group were also significantly lower than in the saline group at 0, 4 and 8 h after surgery (P < 0.05, Fig. 1 ). There was no significant difference in VAS pain scores between the groups at 12, 16 and 24 h after surgery.
Horner's syndrome was observed in 12 patients in the ropivacaine group and in all 12 cases it had disappeared 4 h after surgery. No severe complications or other relevent adverse events were reported in either group. 
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Discussion
The current randomized, double-blind study demonstrated that the incidence of PONV in patients who underwent thyroid surgery under general anaesthesia and received BSCPB with 0.5% ropivacaine was significantly reduced compared with patients who received BSCPB with placebo (saline group). The reduction in the incidence of PONV in the ropivacaine group was most notable up to 4 h after surgery. Patients in the ropivacaine group also experienced less pain in the first 8 h after surgery compared with patients in the saline group. Furthermore, the intraoperative dose of fentanyl and the number of patients who needed fentanyl titration in the PACU were higher in the saline group compared with the ropivacaine group.
The aetiology of PONV after thyroidectomy under general anaesthesia remains unclear, although it often occurs. 1 The present study found that the total incidence of PONV was 75% in patients who underwent thyroidectomy without BSCPB (saline group). Many strategies have been evaluated in the clinical setting to avoid the frequent and often distressing incidence of PONV associated with anaesthesia and surgery, including prophylactic antiemetics, 11, 12 low-dose midazolam 13 and the use of different anaesthetic techniques. 14 Among patients at high risk of PONV, nonpharmacological therapies should be considered if general anaesthesia is used. 15 Local anaesthetic wound infiltration, BSCPB and bilateral combined superficial and deep cervical plexus block have been reported to reduce postoperative opioid requirements. 7, 8, 16, 17 The incidence of PONV, however, was not reduced in these studies. 7, 8, 16, 17 Eti et al. 18 concluded that BSCPB or local anaesthetic wound infiltration with 0.25% bupivacaine did not decrease analgesic requirement after thyroid surgery. In their study, the incidence of nausea in patients administered BSCPB was 53.3% and, in those where no regional block was administered, it was 73.3%; vomiting incidences were 13.3% and 26.6%, respectively. 18 These differences, however, were not statistically significantly different between the groups, which may be attributable to the small number of patients enrolled in the study (n = 15). 18 Shih et al. 19 investigated BSCPB with local anaesthetic drugs in patients who underwent thyroid surgery and showed it to lower postoperative pain and the incidence of overall and severe PONV significantly compared with placebo (saline), however, there were insufficient numbers of patients to detect differences in PONV between treatment groups.
The present study demonstrated a significantly reduced incidence of PONV in patients administered BSCPB. The contrast in study outcome compared with some previous studies 7, 8, 16, 17 may be a result of differences in study design. Notable differences in pain management and anaesthetic techniques used among the studies include: use of regional techniques after skin closure and lower concentration of local anaesthetic; 7, 16 use of propofol-based anaesthesia and bilateral deep cervical plexus block combined with BSCPB; 8 differences in injection technique and use of nefopam; 17 and use of prophylactic dexamethasone. 19 Furthermore, these studies 7,8,16 -19 were not designed to evaluate the incidence of PONV.
Intraoperative use of volatile anaesthetics, fentanyl and the occurrence of postoperative incision pain are all known to increase the incidence of PONV. 20 Reducing the level of general anaesthesia required, reducing the dosage of opioids and providing prolonged postoperative analgesia are important strategies for reducing the incidence of PONV. In contrast to some studies where BSCPB did not have a significant effect on analgesic requirements 21 and pain score, 22 the present study showed that BSCPB with ropivacaine administered before incision alleviated postoperative pain and reduced the use of fentanyl perioperatively. The primary efficacy endpoint of the present study was measured in the 0 -4 h postanaesthesia time period in consideration of analgesic requirement after the use of ropivacaine. Presurgery BSCPB with ropivacaine reduced the incidence of PONV and postoperative pain scores during this time period. The reduced incidence of PONV was probably associated with the reduced postoperative pain scores and opioid requirements in these patients.
A limitation of the present study was that the amount of sevoflurane administered for general anaethesia was not calculated, despite the monitoring of BIS. It has previously been reported, however, that BSCPB performed before surgery can reduce the use of volatile anaesthetics. 19 A further study limitation concerned the fact that adjustments were made to the concentration of sevoflurane whereas no adjustments were made to the concentration of nitrous oxide. Use of nitrous oxide is an anaesthetic risk factor for PONV 4 and avoiding its use has been shown to reduce the incidence of PONV. 23 Using BSCPB for the present study was based on a previous study that reported BSCPB as more effective at reducing pain during and immediately after thyroidectomy 24 Importantly, bilateral deep cervical plexus block combined with BSCPB is associated with more serious complications than BSCPB, including vertebral artery, subarachnoid or epidural injection and phrenic nerve palsy. Phrenic nerve palsy has been shown to occur frequently after deep cervical plexus block. 25 No phrenic nerve palsy or any other severe complications were observed in the present study.
In conclusion, BSCPB with 0.5% ropivacaine administered before surgery can significantly reduce the incidence of PONV and early postoperative pain and also reduce perioperative opioid requirements in thyroidectomy patients undergoing general anaesthesia.
